Viewing Study NCT07431502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-06-02 @ 6:06 PM
Study NCT ID: NCT07431502
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-27
First Post: 2026-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at … View
None Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at … View
None Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at … View
None Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at … View
None Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at … View
Keywords: